Choroidal neovascularization and bevacizumab therapy in Aicardi syndrome

  • Adam S. Wenick
  • Daniel M. Paskowitz
  • M. Zain Tauqir
  • Quan Dong Nguyen
Letter to the Editor


  1. 1.
    Aicardi J (2005) Aicardi syndrome. Brain Dev 27:164–171PubMedCrossRefGoogle Scholar
  2. 2.
    Ospina LH, Nayak H, McCormick AQ (2004) Progressive pigmentation of chorioretinal lesions in Aicardi syndrome. Arch Ophthalmol 122:790PubMedCrossRefGoogle Scholar
  3. 3.
    Palmér L, Zetterlund B, Haard AL, Steneryd K, Kyllerman M (2007) Aicardi syndrome: follow-up investigation of Swedish children born in 1975–2002. Neuropediatrics 38:188–192PubMedCrossRefGoogle Scholar
  4. 4.
    Iturralde D, Meyerle CB, Yannuzzi LA (2006) Aicardi syndrome: chorioretinal lacunae without corpus callosum agenesis. Retina 26:977–978PubMedCrossRefGoogle Scholar
  5. 5.
    McMahon RG, Bell RA, Moore GR, Ludwin SK (1984) Aicardi's syndrome. A clinicopathologic study. Arch Ophthalmol 102:250–253PubMedCrossRefGoogle Scholar
  6. 6.
    Menezes AV, Lewis TL, Buncic JR (1996) Role of ocular involvement in the prediction of visual development and clinical prognosis in Aicardi syndrome. Br J Ophthalmol 80:805–811PubMedCrossRefGoogle Scholar
  7. 7.
    Wu WC, Yeh PT, Chen SN, Yang CM, Lai CC, Kuo HK (2011) Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan. Ophthalmol 118(1):176–183CrossRefGoogle Scholar
  8. 8.
    Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364(7):603–615PubMedCrossRefGoogle Scholar
  9. 9.
    Sisk RA, Berrocal AM, Albini TA, Murray TG (2010) Bevacizumab for the treatment of pediatric retinal and choroidal diseases. Ophthalmic Surg Lasers Imag 41(6):582–592CrossRefGoogle Scholar
  10. 10.
    Glade Bender JL, Adamson PC, Reid JM, Xu L, Baruchel S, Shaked Y, Kerbel RS, Cooney-Qualter EM, Stempak D, Chen HX, Nelson MD, Krailo MD, Ingle AM, Blaney SM, Kandel JJ, Yamashiro DJ, Children's Oncology Group Study (2008) Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol 26(3):399–405PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Adam S. Wenick
    • 1
  • Daniel M. Paskowitz
    • 1
  • M. Zain Tauqir
    • 1
  • Quan Dong Nguyen
    • 1
  1. 1.Retina Division, Wilmer Eye InstituteJohns Hopkins UniversityBaltimoreUSA

Personalised recommendations